TUHURA BIOSCIENCES RSS Feed | Nachrichten - www.finanzen.netwww.finanzen.net bietet Finanznachrichten zum weltweiten BörsengeschehenFinanzenhttps://www.finanzen.netde-definanzen.net GmbHThu, 09 Apr 2026 06:43:10 +0200https://images.finanzen.net/images/finanzen_net_neu.gifTUHURA BIOSCIENCES RSS Feed | Nachrichten - www.finanzen.nethttps://www.finanzen.netTuHURA Biosciences präsentierte Bilanzzahlen zum jüngsten JahresviertelThu, 02 Apr 2026 06:35:06 +0200https://www.finanzen.net/nachricht/aktien/tuhura-biosciences-praesentierte-bilanzzahlen-zum-juengsten-jahresviertel-15591006TuHURA Biosciences hat am 31.03.2026 das Zahlenwerk zum am 31.12.2025 abgelaufenen Jahresviertel vorgestellt.Für das jüngste Jahresviertel wies das Unternehmen ein EPS von -0,13 USD je Aktie aus. Ein Jahr ...

]]>https://www.finanzen.net/nachricht/aktien/tuhura-biosciences-praesentierte-bilanzzahlen-zum-juengsten-jahresviertel-15591006/C O R R E C T I O N -- Global X Investments Canada Inc./Thu, 01 Jan 2026 07:04:00 +0100https://www.finanzen.net/nachricht/aktien/c-o-r-r-e-c-t-i-o-n-global-x-investments-canada-inc-15387737

In the news release, GLOBAL X CONFIRMS 2025 ANNUAL NON-CASH DISTRIBUTIONS, issued 31-Dec-2025 by Global X Investments Canada Inc. over PR Newswire, we are advised by the company that there ...

]]>https://www.finanzen.net/nachricht/aktien/c-o-r-r-e-c-t-i-o-n-global-x-investments-canada-inc-15387737GLOBAL X CONFIRMS 2025 ANNUAL NON-CASH DISTRIBUTIONSWed, 31 Dec 2025 22:00:00 +0100https://www.finanzen.net/nachricht/aktien/global-x-confirms-2025-annual-non-cash-distributions-15387400

TORONTO, Dec. 31, 2025 /CNW/ - Global X Investments Canada Inc. ("Global X") confirmed today the ...

]]>https://www.finanzen.net/nachricht/aktien/global-x-confirms-2025-annual-non-cash-distributions-15387400/C O R R E C T I O N -- Global X Investments Canada Inc./Tue, 23 Dec 2025 23:57:00 +0100https://www.finanzen.net/nachricht/aktien/c-o-r-r-e-c-t-i-o-n-global-x-investments-canada-inc-15377982

In the news release, GLOBAL X ANNOUNCES DECEMBER 2025 DISTRIBUTIONS FOR ITS SUITE OF ETFs, issued 22-Dec-2025 by Global X Investments Canada Inc. over PR Newswire, we ...

]]>https://www.finanzen.net/nachricht/aktien/c-o-r-r-e-c-t-i-o-n-global-x-investments-canada-inc-15377982GLOBAL X ANNOUNCES DECEMBER 2025 DISTRIBUTIONS FOR ITS SUITE OF ETFsTue, 23 Dec 2025 01:10:00 +0100https://www.finanzen.net/nachricht/aktien/global-x-announces-december-2025-distributions-for-its-suite-of-etfs-15375822

TORONTO, Dec. 22, 2025 /CNW/ - Global X Investments Canada Inc. ("Global X") is pleased to announce ...

]]>https://www.finanzen.net/nachricht/aktien/global-x-announces-december-2025-distributions-for-its-suite-of-etfs-15375822TuHURA Biosciences Announces its Release of Kintara's Contingent Value Right (CVR) as Kintara's REM-001 Meets Primary Safety Endpoint Achieving Contractual MilestoneMon, 15 Dec 2025 13:50:00 +0100https://www.finanzen.net/nachricht/aktien/tuhura-biosciences-announces-its-release-of-kintara-s-contingent-value-right-cvr-as-kintara-s-rem-001-meets-primary-safety-endpoint-achieving-contractual-milestone-15358658

Milestone Triggers Release of Shares to Kintara Contingent Value Right (CVR) Holders

TAMPA, Fla., ...

]]>https://www.finanzen.net/nachricht/aktien/tuhura-biosciences-announces-its-release-of-kintara-s-contingent-value-right-cvr-as-kintara-s-rem-001-meets-primary-safety-endpoint-achieving-contractual-milestone-15358658TuHURA Biosciences Provides Corporate Update Following Recent FinancingThu, 11 Dec 2025 13:30:00 +0100https://www.finanzen.net/nachricht/aktien/tuhura-biosciences-provides-corporate-update-following-recent-financing-15351997

Company's lead Phase 3 program of IFx-2.0 as adjunctive therapy with Keytruda® (pembrolizumab) as a first-line therapy for advanced and metastatic Merkel cell carcinoma (MCC), conducted ...

]]>https://www.finanzen.net/nachricht/aktien/tuhura-biosciences-provides-corporate-update-following-recent-financing-15351997TuHURA Biosciences Presents Data Demonstrating the Delta Opioid Receptor (DOR) as a New Target in Overcoming Acquired Resistance to Immune Checkpoint Inhibitors at the 57th ASH Annual Meeting and ...Mon, 08 Dec 2025 13:50:00 +0100https://www.finanzen.net/nachricht/aktien/tuhura-biosciences-presents-data-demonstrating-the-delta-opioid-receptor-dor-as-a-new-target-in-overcoming-acquired-resistance-to-immune-checkpoint-inhibitors-at-the-57th-ash-annual-meeting-and-15342424

Oral Presentation highlighted new scientific evidence that DOR is expressed on tumor-associated Myeloid-Derived Suppressor Cells (MDSCs), and its inhibition decreases immune suppressing capabilities ...

]]>https://www.finanzen.net/nachricht/aktien/tuhura-biosciences-presents-data-demonstrating-the-delta-opioid-receptor-dor-as-a-new-target-in-overcoming-acquired-resistance-to-immune-checkpoint-inhibitors-at-the-57th-ash-annual-meeting-and-15342424GLOBAL X ANNOUNCES ESTIMATED 2025 ANNUAL NON-CASH DISTRIBUTIONThu, 27 Nov 2025 22:00:00 +0100https://www.finanzen.net/nachricht/aktien/global-x-announces-estimated-2025-annual-non-cash-distribution-15318974

TORONTO, Nov. 27, 2025 /CNW/ - Global X Investments Canada Inc. ("Global X") announced today the ...

]]>https://www.finanzen.net/nachricht/aktien/global-x-announces-estimated-2025-annual-non-cash-distribution-15318974TuHURA Biosciences informierte über die jüngsten QuartalsergebnisseSun, 16 Nov 2025 06:35:07 +0100https://www.finanzen.net/nachricht/aktien/tuhura-biosciences-informierte-ueber-die-juengsten-quartalsergebnisse-15281053TuHURA Biosciences lud am 14.11.2025 zur turnusmäßigen Finanzkonferenz und hat dort das Zahlenwerk zum jüngsten Quartal veröffentlicht, das am 30.09.2025 endete.Dabei wurde ein Verlust je Aktie von 0,14 USD ...

]]>https://www.finanzen.net/nachricht/aktien/tuhura-biosciences-informierte-ueber-die-juengsten-quartalsergebnisse-15281053